Monday, April 13, 2026
wellness India Expo

Expert Column

Here the industry leaders, policymakers, guiding lights from academia and sector experts present their individual or collective viewpoints on host of issues. This column is dedicated to their experiences with various aspects of  the bioscience landscape.

Face to Face

“Research must be designed for translation, not just for publications”: Dr...

303
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem

Chat with BioVoice

“Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”

143
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans

R&D

Events